Literature DB >> 15841210

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis.

Sabine Cepok1, Dun Zhou, Rajneesh Srivastava, Stefan Nessler, Susanne Stei, Konrad Büssow, Norbert Sommer, Bernhard Hemmer.   

Abstract

MS is a chronic inflammatory and demyelinating disease of the CNS with as yet unknown etiology. A hallmark of this disease is the occurrence of oligoclonal IgG antibodies in the cerebrospinal fluid (CSF). To assess the specificity of these antibodies, we screened protein expression arrays containing 37,000 tagged proteins. The 2 most frequent MS-specific reactivities were further mapped to identify the underlying high-affinity epitopes. In both cases, we identified peptide sequences derived from EBV proteins expressed in latently infected cells. Immunoreactivities to these EBV proteins, BRRF2 and EBNA-1, were significantly higher in the serum and CSF of MS patients than in those of control donors. Oligoclonal CSF IgG from MS patients specifically bound both EBV proteins. Also, CD8(+) T cell responses to latent EBV proteins were higher in MS patients than in controls. In summary, these findings demonstrate an increased immune response to EBV in MS patients, which suggests that the virus plays an important role in the pathogenesis of disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15841210      PMCID: PMC1077174          DOI: 10.1172/JCI23661

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  A human cDNA library for high-throughput protein expression screening.

Authors:  K Büssow; E Nordhoff; C Lübbert; H Lehrach; G Walter
Journal:  Genomics       Date:  2000-04-01       Impact factor: 5.736

2.  Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid.

Authors:  Gregory P Owens; Alanna M Ritchie; Mark P Burgoon; R Anthony Williamson; John R Corboy; Donald H Gilden
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

3.  Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation.

Authors:  D A Hilton; S Love; A Fletcher; J H Pringle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

4.  B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions.

Authors:  S E Baranzini; M C Jeong; C Butunoi; R S Murray; C C Bernard; J R Oksenberg
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

5.  The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients?

Authors:  M Munch; K Riisom; T Christensen; A Møller-Larsen; S Haahr
Journal:  Acta Neurol Scand       Date:  1998-03       Impact factor: 3.209

6.  Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

Authors:  Y Qin; P Duquette; Y Zhang; P Talbot; R Poole; J Antel
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

7.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis.

Authors:  Heather L E Lang; Helle Jacobsen; Shinji Ikemizu; Christina Andersson; Karl Harlos; Lars Madsen; Peter Hjorth; Leif Sondergaard; Arne Svejgaard; Kai Wucherpfennig; David I Stuart; John I Bell; E Yvonne Jones; Lars Fugger
Journal:  Nat Immunol       Date:  2002-09-03       Impact factor: 25.606

8.  Expression of CCR7 in multiple sclerosis: implications for CNS immunity.

Authors:  Pia Kivisäkk; Don J Mahad; Melissa K Callahan; Keith Sikora; Corinna Trebst; Barbara Tucky; Jerome Wujek; Rivka Ravid; Susan M Staugaitis; Hans Lassmann; Richard M Ransohoff
Journal:  Ann Neurol       Date:  2004-05       Impact factor: 10.422

9.  Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis.

Authors:  M J Walsh; W W Tourtellotte
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  91 in total

Review 1.  Viruses and multiple sclerosis.

Authors:  Gregory P Owens; Don Gilden; Mark P Burgoon; Xiaoli Yu; Jeffrey L Bennett
Journal:  Neuroscientist       Date:  2011-12       Impact factor: 7.519

Review 2.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence.

Authors:  A Ascherio; K L Munger
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

Review 3.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

Review 4.  Multiplexed protein measurement: technologies and applications of protein and antibody arrays.

Authors:  Stephen F Kingsmore
Journal:  Nat Rev Drug Discov       Date:  2006-04       Impact factor: 84.694

Review 5.  Epstein-barr virus: environmental trigger of multiple sclerosis?

Authors:  Jan D Lünemann; Thomas Kamradt; Roland Martin; Christian Münz
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

6.  [Recent advances in the pathogenesis and immunotherapy of multiple sclerosis].

Authors:  R Gold; P Rieckmann
Journal:  Nervenarzt       Date:  2007-09       Impact factor: 1.214

7.  Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis.

Authors:  J D Lünemann; P Huppke; S Roberts; W Brück; J Gärtner; C Münz
Journal:  Neurology       Date:  2008-09-23       Impact factor: 9.910

8.  Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.

Authors:  Michael K Axthelm; Dennis N Bourdette; Gail H Marracci; Weiping Su; Elizabeth T Mullaney; Minsha Manoharan; Steven G Kohama; Jim Pollaro; Ellen Witkowski; Paul Wang; William D Rooney; Lawrence S Sherman; Scott W Wong
Journal:  Ann Neurol       Date:  2011-06-14       Impact factor: 10.422

9.  Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.

Authors:  M P Pender; P A Csurhes; A Lenarczyk; C M M Pfluger; S R Burrows
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-11-17       Impact factor: 10.154

Review 10.  Is the risk of multiple sclerosis related to the 'biography' of the immune system?

Authors:  Bernd Krone; Frank Oeffner; John M Grange
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.